Examining factors associated with excess mortality in older people (age ≥ 70 years) with diabetes – a 10-year cohort study of older people with and without diabetes

Diabetic Medicine

Volumn 34, Issue 3, 2017, Pages 387-395

  Forbes, A ^a   Murrells, T ^a   Sinclair, A J ^b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b ASTON UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; ATRIAL FIBRILLATION; CEREBROVASCULAR ACCIDENT; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; COMORBIDITY ASSESSMENT; DEPRESSION; DIABETES MELLITUS; DIABETIC PATIENT; FEMALE; HEART FAILURE; HUMAN; HYPERTENSION; HYPOTHYROIDISM; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY RISK; OBESITY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; POLYPHARMACY; RISK ASSESSMENT; SEX DIFFERENCE; SURVIVAL RATE; AGING; CLINICAL TRIAL; COMPLICATION; DIABETIC CARDIOMYOPATHY; DIABETIC COMPLICATION; DISEASE EXACERBATION; ELECTRONIC HEALTH RECORD; EPIDEMIOLOGY; MORTALITY; MULTICENTER STUDY; MULTIMODALITY CANCER THERAPY; NATIONAL HEALTH SERVICE; PATHOPHYSIOLOGY; PRIMARY HEALTH CARE; PROPORTIONAL HAZARDS MODEL; SEX FACTOR; SURVIVAL ANALYSIS; UNITED KINGDOM;

AGED; AGING; COHORT STUDIES; COMBINED MODALITY THERAPY; DIABETES COMPLICATIONS; DIABETES MELLITUS; DIABETIC CARDIOMYOPATHIES; DISEASE PROGRESSION; ELECTRONIC HEALTH RECORDS; FEMALE; HEART FAILURE; HUMANS; MALE; MORTALITY; PRIMARY HEALTH CARE; PROPORTIONAL HAZARDS MODELS; SEX FACTORS; STATE MEDICINE; SURVIVAL ANALYSIS; UNITED KINGDOM;

EID: 84971265247     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/dme.13132     Document Type: Article

References (30)

1. Gordon-Dseagu V, Shelton N, Mindell J. Diabetes mellitus and mortality from all-causes, cancer, cardiovascular and respiratory disease: evidence from the Health Survey for England and Scottish Health Survey cohorts. J Diabetes Complicat 2014; 28: 791–797.
2. Campbell PT, Newton C, Patel AV, Jacobs EJ, Gapstur SM. Diabetes and cause-specific mortality in a prospective cohort of one million U.S. adults. Diabetes Care 2012; 35: 1835–1844.
3. Seshasai SRK, Kaptoge S, Thompson A, Di Angelantonio E, Gao P, Sarwar N. Diabetes mellitus, fasting glucose, and risk of cause-specific death. N Engl J Med 2011; 364: 829–841.
4. Barnett K, McMurdo M, Ogston S, Morris A, Evans J. Mortality in people diagnosed with type 2 diabetes at an older age: a systematic review. Age Ageing 2006; 35: 463–468.
5. Huang E, Laiteerapong N, Liu J, John P, Moffet H, Karter A. Rates of complications and mortality in older patients with diabetes mellitus: the diabetes and aging study. JAMA Intern Med 2014; 174: 251–258.
6. Bethel M, Sloan F, Belsky D, Feinglos M. Longitudinal incidence and prevalence of adverse outcomes of diabetes mellitus in elderly patients. Arch Intern Med 2007; 167: 921–927.
7. Hansen L, Olivarius N, Siersma V. 16-year excess all-cause mortality of newly diagnosed type 2 diabetic patients: a cohort study. BMC Public Health 2009; 9: 400–405.
8. Huang ES, Liu JY, Moffet HH, John PM, Karter AJ. Glycemic control, complications, and death in older diabetic patients: the diabetes and aging study. Diabetes Care 2011; 34: 1329–1334.
9. ADA/EASD. Type 2 diabetes, 2015: a patient-centered approach update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2015; 38: 140–149.
10. Laiteerapong N, Iveniuk J, John PM, Laumann EO, Huang ES. Classification of older adults who have diabetes by comorbid conditions, United States, 2005–2006. Prev Chronic Dis 2012; 9: 3–8.
11. Laditka SB, Laditka JN. Active life expectancy of Americans with diabetes: risks of heart disease, obesity, and inactivity. Diabetes Res Clin Pract 2015; 107: 37–45.
12. Ebbesen J, Buajorder I, Erickson J, Brors O, Coleman S, Katon W et al. Depression and death in diabetes; 10-year follow-up of all-cause and cause-specific mortality in a diabetic cohort. Psychosomatics 2013; 54: 428–436.
13. Jyrkkä J, Enlund H, Korhonen MJ, Sulkava R, Hartikainen S. Polypharmacy status as an indicator of mortality in an elderly population. Drugs Aging 2009; 26: 1039–1048.
14. Bauer S, Nauck MA. Polypharmacy in people with Type 1 and Type 2 diabetes is justified by current guidelines – a comprehensive assessment of drug prescriptions in patients needing inpatient treatment for diabetes-associated problems. Diabet Med 2014; 31: 1078–1085.
15. Bramlage P, Gitt A, Binz C, Krekler M, Deeg E, Tschöpe D. Oral antidiabetic treatment in Type 2 diabetes in the elderly: balancing the need for glucose control and the risk of hypoglycaemia. Cardiovasc Diabetol 2012; 11: 122–129.
16. Imamura F, Mukamal KJ, Meigs JB, Luchsinger JA, Siscovick DS et al. Risk factors for type 2 diabetes mellitus preceded by β–cell dysfunction, insulin resistance, or both in older adults: the Cardiovascular Health Study. Am J Epidemiol 2013; 177: 1418–1429.
17. Gatling W, Guzder RN, Turnbull JC, Budd S, Mullee MA. The Poole Diabetes Study: how many cases of type 2 diabetes are diagnosed each year during normal health care in a defined community? Diabetes Res Clin Pract 2001; 53: 107–112.
18. Blak BT, Thompson M, Dattani H, Bourke A. Generalisability of The Health Improvement Network (THIN) database: demographics, chronic disease prevalence and mortality rates. Inform Primary Care 2011; 19: 251–255.
19. Murrells T, Ball J, Maben J, Ashworth M, Griffiths P. Nursing consultations and control of diabetes in general practice: a retrospective observational study. Br J Gen Pract 2015; 65: 639–642.
20. Khan N, Perera R, Harper S, Rose W. Adaptation and validation of the Charlson Index for Read/OXMIS coded databases. BMC Fam Pract 2010; 11: 1.
21. Gómez C, Vega-Quiroga S, Bermejo-Pareja F, Medrano MJ, Louis ED, Benito-León J. Polypharmacy in the elderly: a marker of increased risk of mortality in a population-based prospective study (NEDICES). Gerontology 2015; 61: 301–309.
22. Preis SR, Hwang SJ, Coady S, Pencina MJ, D'Agostino RB Sr, Savage PJ et al. Trends in all-cause and cardiovascular disease mortality among women and men with and without diabetes mellitus in the Framingham Heart Study, 1950 to 2005. Circulation 2009; 119: 1728–1735.
23. Grembowski D, Ralston JD, Anderson ML. Hemoglobin A1c, comorbid conditions and all-cause mortality in older patients with DM: a retrospective 9–year cohort study. Diabetes Res Clin Pract 2014; 106: 373–382.
24. Tancredi M, Rosengren A, Svensson A, Kosiborod M, Pivodic A, Gudbjörnsdottir S et al. Excess mortality among persons with Type 2 diabetes. N Engl J Med 2015; 373: 1720–1732.
25. Bertoni AG, Hundley WG, Masing MW, Bonds DE, Burke GL, Goff DC. Heart failure prevalence, incidence, and mortality in the elderly with diabetes. Diabetes Care 2004; 27: 699–703.
26. Wang Y, Negishi T, Negishi K, Marwick TH. Prediction of heart failure in patients with type 2 diabetes mellitus – a systematic review and meta-analysis. Diabetes Res Clin Pract 2014; 108: 55–66.
27. Zinman B, Wanner C, Lachin J, Fitchett D, Bluhmki E, Hantel S et al. for the EMPA-REG OUTCOME Investigators. Empagliflozin, cardiovascular outcomes, and mortality in Type 2 diabetes. N Engl J Med 2015; 373: 2117–2128.
28. Laiteerapong N, Iveniuk J, John PM, Laumann EO, Huang ES. Classification of older adults who have diabetes by comorbid conditions, United States, 2005–2006. Prev Chronic Dis 2012; 9: 3–8.
29. Nilsson G, Hedger P, Ohrvik J. Survival of the fattest: unexpected findings about hyperglycaemia and obesity in a population based study of 75-year-olds. BMJ Open 2011; 1: e000012.
30. Cruz-Jentoft AJ, Carpena-Ruiz M, Montero-Errasquín B, Sánchez-Castellano C, Sánchez-García E. Exclusion of older adults from ongoing clinical trials about type 2 diabetes mellitus. J Am Geriatr Soc 2013; 61: 734–738.